-
EP1158045
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1158045
| EP1158045 - Culture conditions allowing to modulate the expression of CYP3A4 in CaCo2 cells [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.02.2003 Database last updated on 13.11.2024 | Most recent event Tooltip | 15.02.2003 | Application deemed to be withdrawn | published on 02.04.2003 [2003/14] | Applicant(s) | For all designated states UNIVERSITE CATHOLIQUE DE LOUVAIN Halles Universitaires Place de l'Université, 1 1348 Louvain-la-Neuve / BE | [N/P] |
| Former [2001/48] | For all designated states UNIVERSITE CATHOLIQUE DE LOUVAIN Halles Universitaires Place de l'Université, 1 1348 Louvain-la-Neuve / BE | Inventor(s) | 01 /
Schneider, Yves-Jacques rue de la draisienne, 152 5500 Flamignoul / BE | 02 /
Burteau, Nathalie rue des Glacières 47 6001 Marcinelle / BE | [2001/48] | Representative(s) | De Clercq, Ann G. Y. De Clercq & Partners cvba Edgard Gevaertdreef 10 a 9830 Sint-Martens-Latem / BE | [N/P] |
| Former [2001/48] | De Clercq, Ann De Clercq, Brants & Partners cv., Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem / BE | Application number, filing date | 00870108.8 | 17.05.2000 | [2001/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1158045 | Date: | 28.11.2001 | Language: | EN | [2001/48] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.03.2001 | Classification | IPC: | C12N5/08, G01N33/50 | [2001/48] | CPC: |
C12N5/0679 (EP);
C12N5/0693 (EP);
C12N2501/11 (EP);
C12N2501/33 (EP);
C12N2501/39 (EP);
C12N2503/02 (EP)
| Designated contracting states | (deleted) [2002/33] |
| Former [2001/48] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE | Title | German: | Kulturzustände die erlauben die Modulierung der Expression von CYP3A4 in CaCo2 Zellen | [2001/48] | English: | Culture conditions allowing to modulate the expression of CYP3A4 in CaCo2 cells | [2001/48] | French: | Conditions de culture permettant de moduler l'expression de CYP3A4 dans des cellules CaCo2 | [2001/48] | Biological material | This application mentions deposited biological material, check the file for details | Examination procedure | 26.09.2000 | Loss of particular rights, legal effect: Claims | 25.10.2000 | Despatch of communication of loss of particular rights: Claims {1} | 29.05.2002 | Application deemed to be withdrawn, date of legal effect [2003/14] | 29.10.2002 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2003/14] | Fees paid | Penalty fee | Penalty fee Rule 85a EPC 1973 | 26.07.2002 | AT M01 Not yet paid | 26.07.2002 | BE M01 Not yet paid | 26.07.2002 | CH M01 Not yet paid | 26.07.2002 | CY M01 Not yet paid | 26.07.2002 | DE M01 Not yet paid | 26.07.2002 | DK M01 Not yet paid | 26.07.2002 | ES M01 Not yet paid | 26.07.2002 | FI M01 Not yet paid | 26.07.2002 | FR M01 Not yet paid | 26.07.2002 | GB M01 Not yet paid | 26.07.2002 | GR M01 Not yet paid | 26.07.2002 | IE M01 Not yet paid | 26.07.2002 | IT M01 Not yet paid | 26.07.2002 | LU M01 Not yet paid | 26.07.2002 | MC M01 Not yet paid | 26.07.2002 | NL M01 Not yet paid | 26.07.2002 | PT M01 Not yet paid | 26.07.2002 | SE M01 Not yet paid | Penalty fee Rule 85b EPC 1973 | 26.07.2002 | M01 Not yet paid | Additional fee for renewal fee | 31.05.2002 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US5856189 (WATKINS PAUL B [US], et al) [A] 1-10 * column W *; | [X] - FISHER JEANNINE M ET AL, "Midazolam metabolism by modified Caco-2 monolayers: Effects of extracellular protein binding.", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, (199905), vol. 289, no. 2, ISSN 0022-3565, pages 1143 - 1150, XP000982476 [X] 1,2,4-10 * the whole document * | [A] - SCHUETZ ERIN G ET AL, "Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.", MOLECULAR PHARMACOLOGY, (1996), vol. 49, no. 2, ISSN 0026-895X, pages 311 - 318, XP000906895 [A] 1-10 * the whole document * | [DA] - SCHMKIEDLIN-REN PHYLLSSA ET AL, "Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1-alpha,25-dihydroxyvitamin D-3.", MOLECULAR PHARMACOLOGY, (1997), vol. 51, no. 5, ISSN 0026-895X, pages 741 - 754, XP002161257 [DA] 1-10 * the whole document * |